Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Gains from Sales and Divestitures (2013 - 2026)

Healthstream (HSTM) reported Gains from Sales and Divestitures of $95000.0 for Q1 2026, down 25.2% year-over-year from $127000.0 in Q1 2025, and down 52.02% on a QoQ basis from $198000.0 in Q4 2025.

Healthstream (HSTM) has 11 years of Gains from Sales and Divestitures data on file, last reported at $95000.0 in Q1 2026.

  • Quarterly Gains from Sales and Divestitures fell 25.2% year-over-year to $95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95000.0 (down 25.2% YoY) and the FY2025 annual result came in at $198000.0, up 13.14% from the prior year.
  • Gains from Sales and Divestitures eased to $95000.0 in Q1 2026 per HSTM's latest filing, from $198000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $198000.0 in Q4 2025 and bottomed at $15000.0 in Q3 2025.
  • The 5-year median for Gains from Sales and Divestitures is $125000.0 (2022), against an average of $114250.0.
  • The widest annual swing landed in 2022, when Gains from Sales and Divestitures jumped 33.7%; it then dropped 25.2% in 2026.
  • Tracing HSTM's Gains from Sales and Divestitures over 5 years: stood at $123000.0 in 2022, then increased by 29.27% to $159000.0 in 2023, then gained by 10.06% to $175000.0 in 2024, then increased by 13.14% to $198000.0 in 2025, then sank by 52.02% to $95000.0 in 2026.
  • Per Business Quant, the three latest HSTM Gains from Sales and Divestitures figures stand at $95000.0 (Q1 2026), $198000.0 (Q4 2025), and $15000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Healthstream 752.32 Mn 685.82 Mn 68.24 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 95,000.00
Mar 31, 2026 95,000.00
Dec 31, 2025 198,000.00
Dec 31, 2025 198,000.00
Sep 30, 2025 15,000.00
Sep 30, 2025 15,000.00
Jun 30, 2025 22,000.00
Jun 30, 2025 22,000.00
Mar 31, 2025 127,000.00
Mar 31, 2025 127,000.00
Dec 31, 2024 175,000.00
Dec 31, 2024 175,000.00
Dec 31, 2023 159,000.00
Dec 31, 2023 159,000.00
Dec 31, 2022 123,000.00
Dec 31, 2022 123,000.00
Dec 31, 2021 92,000.00
Dec 31, 2021 92,000.00
Dec 31, 2020 90,000.00
Dec 31, 2020 90,000.00
Dec 31, 2019 82,000.00
Dec 31, 2019 82,000.00
Dec 31, 2018 73,000.00
Dec 31, 2018 73,000.00
Jun 30, 2018 3,500.00
Jun 30, 2018 3,500.00
Dec 31, 2017 77,000.00
Dec 31, 2017 77,000.00
Dec 31, 2013 16,000.00
Dec 31, 2013 16,000.00